ArticleAnnals of surgical oncology2026
CT-based Intratumoral Heterogeneity Score for Preoperative Prediction of Lymphovascular Invasion and Prognosis in Lung Adenocarcinoma: A Multicenter Validation and Radiogenomic Interpretation.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLymphovascular invasion (LVI) is a key determinant of recurrence and survival in lung adenocarcinoma (LUAD), but preoperative identification remains challenging. We developed and validated a CT-based intratumoral heterogeneity (ITH) score for LVI prediction, prognostic stratification, and exploratory radiogenomic interpretation.
methodsWe retrospectively included 1322 patients from three institutions and one public dataset. The discovery cohort was divided into training (n = 590) and internal validation (n = 253) sets; an independent cohort (n = 362) was used for external validation and prognostic analysis. A Stanford Radiogenomics set (n = 117) was used for exploratory transcriptomic analysis. Multiple machine learning algorithms were trained using the same feature matrix and cohort partitions.
resultsRandom forest was selected as the final classifier, with AUCs of 0.886 (95% confidence interval [CI] 0.842-0.923) in internal validation and 0.850 (95% CI 0.806-0.892) in external validation. The model showed acceptable calibration and positive net benefit across low-to-intermediate threshold probabilities. High ITH remained associated with worse recurrence-free survival (hazard ratio [HR] 12.92; 95% CI 3.90-42.78; P < 0.001) and overall survival (HR 26.47; 95% CI 3.52-198.76; P = 0.001). Exploratory radiogenomic analysis showed enrichment of hypoxia-, angiogenesis-, epithelial-mesenchymal transition-, and glycolysis-related pathways.
conclusionsThe CT-based ITH score may support preoperative risk stratification for LVI and prognosis in LUAD. Radiogenomic findings suggest potential biological correlates and should be considered hypothesis-generating.
Indexed as
Identifiers
42484818What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.